Amgen Inc.
AMGN
$307.31
$7.012.33%
Headlines
5/8/2024
-
Ticker Report
5/8/2024
-
Insider Monkey
5/8/2024
-
Insider Monkey
5/8/2024
-
Zacks Investment Research
5/8/2024
-
Ticker Report
5/7/2024
-
InvestorPlace
5/7/2024
-
Insider Monkey
5/7/2024
-
Benzinga
5/7/2024
-
CNBC: US News
5/7/2024
-
Bizjournals.com - Health Care News
5/7/2024
-
Ticker Report
5/7/2024
-
Ticker Report
5/7/2024
-
Zacks Investment Research
5/7/2024
-
Zacks Investment Research
5/7/2024
-
Zacks Investment Research
5/7/2024
-
Tickeron - Technical Analysis
5/7/2024
-
Ticker Report
5/6/2024
-
TheStreet.com - Investing
5/6/2024
-
Investopedia Headlines
5/6/2024
-
The Fly
5/6/2024
-
Dividend Channel
5/6/2024
-
Market News Video
5/6/2024
-
Market News Video
5/6/2024
-
Ticker Report
5/6/2024
-
Zacks Investment Research
Filings
Friday, May 3, 2024
Sunday, March 31, 2024
Week of Apr 22 and 26 (est)
Price History
Corporate Info
805 447 1000
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Business Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
more